Skip to main content
. 2020 Apr 27;7(1):e14139. doi: 10.2196/14139

Table 4.

Mean (SD) of self-reported outcome measures of the study population (N=42).

Measure Intervention group (n=15) Control group 1 (n=15) Control group 2 (n=12) Odds ratio (95% CI)a P value
HOOSb





Pain






T1c 88.8 (7.6) 71.7 (17.1) 73.5 (15.9) 1.24 (0.93-1.64) .14


T2d 94.0 (3.4) 87.9 (10.7) 78.5 (16.6) 1.19 (0.98-1.45) .09


T3e 98.7 (2.1) 85.1 (12.5) 85.6 (11.3) 1.29 (0.94-1.77) .12

Other symptoms






T1 75.3 (13.2) 68.0 (18.9) 62.1 (14.1) 1.03 (0.97-1.09) .33


T2 82.3 (10.0) 78.7 (15.8) 74.6 (13.1) 1.04 (0.96-1.13) .37


T3 91.0 (6.0) 76.3 (13.0) 77.5 (17.7) 1.10 (1.00-1.21) .06

Function in ADLf






T1 76.5 (8.0) 60.6 (17.0) 58.1 (15.3) 1.22 (0.94-1.57) .13


T2 92.8 (8.5) 79.0 (11.3) 69.7 (14.8) 1.24 (0.99-1.55) .06


T3 96.8 (3.6) 80.0 (15.6) 79.1 (15.6) 1.25 (0.94-1.67) .13

Function in sport and recreational activities





T1 70.0 (18.8) 26.7 (20.1) 29.7 (24.3) 1.10 (1.01-1.20) .04


T2 76.3 (20.5) 63.8 (26.1) 49.1 (21.6) 1.04 (1.00-1.07) .04


T3 82.5 (11.6) 59.6 (19.3) 64.9 (24.1) 1.09 (1.01-1.17) .03

Hip-related quality of life






T1 50.8 (15.1) 45.8 (18.3) 43.2 (19.5) 1.04 (0.99-1.10) .11


T2 75.4 (14.8) 71.3 (19.7) 63.0 (21.4) 1.03 (0.99-1.07) .21


T3 88.8 (8.9) 71.3 (20.2) 69.3 (22.5) 1.09 (1.02-1.17) .02
SF-36g





Physical functioning






T1 54.8 (15.9) 41.1 (20.2) 36.3 (20.6) 1.04 (1.00-1.08) .09


T2 86.0 (6.8) 62.6 (19.2) 538 (18.0) 1.30 (0.89-1.91) .17


T3 89.0 (7.1) 65.0 (18.9) 59.2 (20.8) 1.26 (0.99-1.60) .07

Role limitations: physical






T1 20.0 (34.3) 23.3 (29.1) 6.3 (15.5) 1.01 (0.99-1.04) .35


T2 70.0 (42.5) 38.3 (42.1) 37.5 (34.5) 1.04 (1.00-1.08) .04


T3 93.3 (25.8) 56.7 (44.8) 45.8 (39.7) 1.04 (1.00-1.08) .03

General health perception






T1 83.1 (15.3) 77.4 (15.9) 66.9 (17.3) 1.00 (0.94-1.07) .91


T2 86.1 (13.5) 73.9 (20.8) 63.0 (22.2) 1.05 (0.97-1.13) .26


T3 84.8 (21.5) 72.6 (14.8) 63.4 (31.8) 1.01 (0.97-1.07) .57

aConditional logistic regression adjusted for baseline for comparison of the two control groups and intervention group.

bHOOS: Hip disability and Osteoarthritis Outcome Score; scale of 0-100 (0 = extreme symptoms, 100 = no symptoms).

cTI: 4 weeks.

dT2: 12 weeks.

eT3: 6 months.

fADL: activities in daily living.

gSF-36: 36-item Short Form Health Survey; scale of 0-100 (higher score = better perceived health or functioning).